EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Characterization, and In Vitro Evaluation of New Amino‐Alcohol Quinolines as Promising Antimycobacterial Agents

Elise Si Ahmed Charrier iD, François Peltier iD, Jean-François Raimbert iD, Marie Perret, Claire Andréjak, Alexandra Dassonville-Klimpt iD, Pascal Sonnet iD

ChemMedChem · 28.10.2026 · 21 (20)

DOI: 10.1002/cmdc.70543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 22.10.2026. Verfasst von Elise Si Ahmed Charrier und 6 weiteren Autor:innen. Beteiligte Einrichtung: AGents Infectieux, Résistance et chimiothérapie, UR4294, UFR de Pharmacie, Université de Picardie Jules Verne, Amiens, France. Hauptthemen laut MEDLINE: Quinolines, Amino Alcohols, Anti-Bacterial Agents, Mycobacterium avium Complex. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université de Picardie Jules Verne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontuberculous mycobacteria (NTM) mainly Mycobacterium avium complex (MAC), are emerging pathogens responsible for pulmonary infections. Therefore, the effectiveness of the gold standard treatment is compromised by the emergence of intrinsic and acquired resistance of MAC. In this context, seventeen amino‐alcohol quinolines as mefloquine analogs were developed as part of this work. Studies on the physicochemical properties, cytotoxicity and activity of these quinoline‐based compounds, in relation to their structures, highlighted the important role of the trifluoromethyl and piperazine moieties. Thus, ( R )‐ 4c was identified as the most promising anti‐MAC compound with the highest selectivity index value of 5.8. It was tested, in two‐drug combinations, using a checkerboard assays with the standard antibiotics (clarithromycin, rifampicin and ethambutol), demonstrating an additive effect with each antibiotic of this gold standard treatment. These results confirm the potential of amino‐alcohol quinolines as alternative of current anti‐NTM agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesAmino AlcoholsAnti-Bacterial AgentsMycobacterium avium ComplexMicrobial Sensitivity TestsStructure-Activity RelationshipHumansMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

amino‐alcohol quinolinesasymmetric synthesisin vitro evaluationnontuberculous mycobacteriaphysicochemical properties

Substanzen

QuinolinesAmino AlcoholsAnti-Bacterial Agents

Autor:innen und Institutionen

  • AGents Infectieux, Résistance et chimiothérapie, UR4294, UFR de Pharmacie, Université de Picardie Jules Verne, Amiens, France.
  • Département de Bactériologie, CHU Amiens-Picardie, Amiens, France.
  • Service de Pneumologie, CHU Amiens-Picardie, Amiens, France.

ORCID-Profile: Elise Si Ahmed Charrier, François Peltier, Jean-François Raimbert, Alexandra Dassonville-Klimpt, Pascal Sonnet

Förderung

  • Université de Picardie Jules Verne

Zitieren

APA

Si Ahmed Charrier, E., Peltier, F., Raimbert, J. F., Perret, M., Andréjak, C., Dassonville-Klimpt, A., & Sonnet, P. (2026). Synthesis, Characterization, and In Vitro Evaluation of New Amino‐Alcohol Quinolines as Promising Antimycobacterial Agents. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70543

Vancouver

Si Ahmed Charrier E, Peltier F, Raimbert JF, Perret M, Andréjak C, Dassonville-Klimpt A, et al. Synthesis, Characterization, and In Vitro Evaluation of New Amino‐Alcohol Quinolines as Promising Antimycobacterial Agents. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70543

BibTeX
@article{SiAhmedCharrier2026,
  author = {Si Ahmed Charrier, Elise and Peltier, François and Raimbert, Jean-François and Perret, Marie and Andréjak, Claire and Dassonville-Klimpt, Alexandra and Sonnet, Pascal},
  title = {Synthesis, Characterization, and In Vitro Evaluation of New Amino‐Alcohol Quinolines as Promising Antimycobacterial Agents},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70543}
}
Kostenlos starten →